Adiponectin Pathways: A New Hope for NASH
Adiponectin, a vital hormone in liver health, holds promise in addressing nonalcoholic steatohepatitis (NASH) through its beneficial roles in inflammation management and metabolic regulation. The advent of treatments like JT003 exemplifies innovative strategies targeting adiponectin pathways, offering hope for improved management of this severe condition. Understanding these therapeutic avenues is essential for advancing liver disease […]
3 minute read